how long takes retatrutide to kick after tirzepatide vs Tirzepatide: Which Weight-Loss Drug Is Better? Retatrutide for weight loss: how

Participants were followed through Swedish national registers between 2009 and 2022

[cited 2024 Nov 20]

Gut Health and Side Effects One of the most common side effects of GLP-1 medications is nausea, bloating, and constipation

The Bottom Line The GLP-1 crackdown is a language enforcement campaign, and it is still accelerating

Projected FDA Approval Timeline: 20272028 Based on the Phase 3 timeline and typical FDA review periods, analysts and Eli Lilly's own investor communications have suggested a potential NDA (New Drug Application) submission in 20262027, with FDA approval potentially following in 20272028

Avoid large, heavy meals, which may exacerbate digestive symptoms